Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sildenafil Citrate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Aspargo Laboratories
Deal Size : Undisclosed
Deal Type : Acquisition
Aspargo Acquires Bandol Sildenafil Spray, Currently Marketed In Spain
Details : BANDOL®, offered in a convenient and discreet metered dose container that delivers the equivalent of 12.5 mg of Sildenafil per actuation, is manufactured in Spain and is prescribed predominantly by primary care physicians and urologists.
Product Name : Bandol
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 05, 2022
Lead Product(s) : Sildenafil Citrate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Aspargo Laboratories
Deal Size : Undisclosed
Deal Type : Acquisition
Reset All
